Cite

HARVARD Citation

    Ackermans, N. et al. (2019). Effect of different doses of gadolinium contrast agent on clinical outcomes in MS. Multiple sclerosis journal, experimental, translational and clinical. 5 (1), p. . [Online]. 
  
Back to record